Foundayo Drug Interactions: Complete Guide to CYP3A4, Statins & More

Before starting Foundayo (orforglipron), every patient should have a thorough medication review. Unlike injectable GLP-1 receptor agonists, Foundayo is an oral small molecule processed through the liver's CYP3A4 enzyme system, which means it has a different and more complex drug interaction profile than semaglutide or tirzepatide.

This guide covers the clinically significant interactions identified in the ATTAIN-1 and ATTAIN-2 clinical trials and the prescribing information, including which drugs require dose adjustments, which should be avoided entirely, and how delayed gastric emptying affects everything else you take by mouth.

Quick Answer

Foundayo is metabolized by CYP3A4, so strong CYP3A4 inhibitors cap your maximum dose at 9 mg, strong CYP3A4 inducers should be avoided entirely, simvastatin must be limited to 20 mg daily, and oral contraceptives may be less effective during dose titration. Delayed gastric emptying can also alter the absorption of other oral medications.

CYP3A4 Metabolism: Why It Matters

Foundayo (orforglipron) is primarily metabolized by CYP3A4, one of the most important drug-metabolizing enzymes in the liver and intestinal wall. CYP3A4 is responsible for processing roughly half of all prescription drugs, which makes it a common site for drug interactions.

When another medication inhibits CYP3A4, Foundayo is broken down more slowly, leading to higher blood levels and increased risk of side effects. When another medication induces (speeds up) CYP3A4, Foundayo is cleared too quickly, potentially reducing its efficacy below therapeutic levels.

Strong CYP3A4 Inhibitors: Dose Cap at 9 mg

If you are taking a strong CYP3A4 inhibitor, the maximum recommended dose of Foundayo is 9 mg daily. Co-administration can increase orforglipron plasma concentrations by approximately 2 to 2.5 times, significantly raising the risk of GI side effects such as nausea, vomiting, and diarrhea.

Common strong CYP3A4 inhibitors include:

• Clarithromycin (macrolide antibiotic)
• Itraconazole (antifungal)
• Ketoconazole (antifungal)
• Posaconazole (antifungal)
• Voriconazole (antifungal)

If you need a short course of one of these drugs (e.g., clarithromycin for an infection), your prescriber may temporarily reduce your Foundayo dose rather than discontinuing it. Discuss this proactively rather than stopping either medication on your own.

OATP1B Inhibitors: Avoid Co-Administration

Drugs that inhibit the OATP1B1/1B3 hepatic uptake transporters can further increase systemic exposure to Foundayo. The most clinically relevant example is ritonavir, a protease inhibitor used in HIV treatment and as a pharmacokinetic booster for other antivirals.

Ritonavir is both a strong CYP3A4 inhibitor and an OATP1B inhibitor, creating a dual interaction mechanism. If you require ritonavir-containing regimens (including ritonavir-boosted nirmatrelvir for COVID-19), consult your prescriber about temporarily holding Foundayo.

Strong CYP3A4 Inducers: Avoid Entirely

Strong CYP3A4 inducers accelerate the metabolism of Foundayo, potentially reducing blood levels below the therapeutic threshold. These should be avoided during Foundayo therapy:

• Carbamazepine (anticonvulsant)
• Phenytoin (anticonvulsant)
• Rifampin (antibiotic, commonly used for tuberculosis)
• St. John's Wort (herbal supplement)
• Phenobarbital (barbiturate)

If you take one of these medications for epilepsy or another chronic condition, Foundayo may not be the right GLP-1 for you. Discuss alternatives with your prescriber — injectable GLP-1s like semaglutide and tirzepatide are not metabolized by CYP3A4 and may be better options.

Simvastatin: Max 20 mg Daily

Foundayo increases exposure to simvastatin's active acid metabolite by approximately 2-fold. This is clinically important because higher simvastatin levels increase the risk of myopathy and rhabdomyolysis — rare but serious muscle breakdown conditions.

The prescribing information limits simvastatin to a maximum of 20 mg daily when co-administered with Foundayo. If you are currently on simvastatin 40 mg or 80 mg, your prescriber should either reduce the dose or switch you to a different statin.

Good news: Atorvastatin (Lipitor) and rosuvastatin (Crestor) do not have clinically meaningful interactions with Foundayo and can be used at standard doses. If you need high-intensity statin therapy, a switch to one of these is straightforward.

Oral Contraceptives: Use Backup Protection

Foundayo's delayed gastric emptying can reduce the absorption of oral contraceptives, potentially lowering their effectiveness. This is especially relevant during dose titration periods, when gastric emptying effects are changing.

The clinical recommendation is to use a barrier method (condoms, diaphragm) for 30 days after each Foundayo dose increase. Once you are on a stable dose, oral contraceptive absorption normalizes and backup methods may no longer be necessary — but confirm with your prescriber.

Non-oral contraceptive methods (IUD, implant, injection, patch) are not affected by gastric emptying and do not require any adjustment.

Delayed Gastric Emptying: Effects on All Oral Medications

Beyond specific drug interactions, Foundayo's effect on gastric motility can alter the absorption profile of virtually any oral medication. This is the same concern seen with all GLP-1 receptor agonists, but it is worth considering systematically:

• Medications requiring rapid absorption (e.g., acetaminophen for acute pain) may take longer to reach effective levels.
• Narrow therapeutic index drugs (e.g., levothyroxine, warfarin) should be monitored more closely, especially during dose changes.
• Timing separation: Consider taking time-sensitive medications at least 1 hour before or 2 hours after Foundayo to minimize absorption variability.

Drug Interaction Summary Table

Drug / Class	Interaction Mechanism	Clinical Action
Clarithromycin	Strong CYP3A4 inhibitor	Cap Foundayo at 9 mg/day
Itraconazole / Ketoconazole	Strong CYP3A4 inhibitor	Cap Foundayo at 9 mg/day
Ritonavir	CYP3A4 inhibitor + OATP1B inhibitor	Avoid co-administration
Carbamazepine / Phenytoin	Strong CYP3A4 inducer	Avoid co-administration
Rifampin	Strong CYP3A4 inducer	Avoid co-administration
St. John's Wort	Strong CYP3A4 inducer	Avoid co-administration
Simvastatin	2x active metabolite exposure	Max 20 mg/day; switch to atorvastatin or rosuvastatin if higher dose needed
Atorvastatin / Rosuvastatin	No clinically significant interaction	No adjustment needed
Oral Contraceptives	Delayed absorption from gastric emptying	Use barrier method for 30 days after each dose increase
Levothyroxine	Delayed absorption from gastric emptying	Monitor TSH; take 1 hr before Foundayo

For a full pre-start checklist including medication review, see our Starting Foundayo checklist.

What to Tell Your Prescriber

Before starting Foundayo, bring a complete list of everything you take — prescription medications, over-the-counter drugs, and supplements. Pay special attention to:

• Any antifungal or antibiotic you take regularly or intermittently
• Your exact statin name and dose
• Whether you use oral contraceptives
• Any anticonvulsant medications
• Herbal supplements, especially St. John's Wort
• HIV/hepatitis antivirals

Most drug interactions with Foundayo are manageable with dose adjustments or medication substitutions. The key is identifying them before you start, not after side effects appear.

Bottom Line

Foundayo's CYP3A4 metabolism creates a drug interaction profile that is different from injectable GLP-1s. If you take strong CYP3A4 inhibitors, your max Foundayo dose is 9 mg. If you take strong CYP3A4 inducers, Foundayo may not work effectively. Simvastatin users need a dose cap or statin switch. And oral contraceptive users should use backup protection during titration. A thorough medication review before starting eliminates nearly all of these risks.

For more on side effects and timeline, see our week-by-week Foundayo side effects guide.